Alkermes' Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NAS: ALKS) announced today that its corporate presentation will be webcast live at the Morgan Stanley Global Healthcare Conference on Monday, Sept. 9, 2013, at 3:15 p.m. EDT (8:15 p.m. BST) from the Grand Hyatt New York. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Rebecca Peterson, +1 781-609-6378
KEYWORDS: United Kingdom United States Europe North America New York Ireland
The article Alkermes' Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.